Genetic variant identified as potential predictor for severe ulcerative colitis

The HLA-DRB1*01:03 genetic variant is associated with severe ulcerative colitis, significantly raising the risk of major surgeries and hospitalizations.

So Bad It Is Good

You’re reading a copy of this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter

July 3, 2023

Ancient DNA reveals first prehistoric cases of Turner and Jacob’s syndromes

Ancient DNA reveals first prehistoric cases of Turner and Jacob’s syndromes, with new technique enhancing chromosome analysis

January 14, 2024

DEFENCE PATENT PORTFOLIO AT THE FOREFRONT OF SUCCESS – Biotech Investments

EQS-News: Defence Therapeutics Inc. / Key word(s): Patent Defence Therapeutics Inc.: DEFENCE PATENT PORTFOLIO AT THE FOREFRONT OF SUCCESS 28.06.2023 / 17:21 CET/CEST The issuer

June 29, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.